Association between High-Density Lipoprotein Cholesterol to Apolipoprotein A-I Ratio and Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study

Table 4

Univariable analysis for factors associated with NAFLD.

Variables	OR	95% CI	value
Gender (male/female)	2.055	1.857–2.275	<0.001
Age (year)	1.011	1.008–1.013	<0.001
Body mass index (kg/m^2)	1.635	1.598–1.674	<0.001
Waist circumference (cm)	1.149	1.141–1.157	<0.001
Systolic blood pressure (mmHg)	1.030	1.027–1.032	<0.001
Diastolic blood pressure (mmHg)	1.053	1.048–1.057	<0.001
Alanine aminotransferase (U/L)	1.056	1.052–1.060	<0.001
Aspartate aminotransferase (U/L)	1.050	1.045–1.056	<0.001
γ-Glutamyl transferase (U/L)	1.020	1.018–1.022	<0.001
Triglyceride (mmol/L)	2.770	2.600–2.951	<0.001
Total cholesterol (mmol/L)	1.339	1.279–1.402	<0.001
LDL-C (mmol/L)	1.145	1.078–1.216	<0.001
Fasting plasma glucose (mmol/L)	1.478	1.408–1.552	<0.001
Serum uric acid (μmol/L)	1.008	1.008–1.009	<0.001
HbA1c (%)	2.062	1.902–2.235	<0.001
HDL-C/apo A-I	0.551	0.433–0.701	<0.001

HbA1c, glycated hemoglobin A1c; HDL-C/apo A-I, high-density lipoprotein cholesterol to apolipoprotein A-I ratio; LDL-C, low-density lipoprotein cholesterol.